Last reviewed · How we verify
Nivea, Topical Cream — Competitive Intelligence Brief
marketed
Dermatology
Small molecule
Live · refreshed every 30 min
Target snapshot
Nivea, Topical Cream (Nivea, Topical Cream) — University of Toronto. Nivea cream provides emollient and moisturizing effects by forming an occlusive barrier on the skin surface to reduce transepidermal water loss.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Nivea, Topical Cream TARGET | Nivea, Topical Cream | University of Toronto | marketed |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Nivea, Topical Cream CI watch — RSS
- Nivea, Topical Cream CI watch — Atom
- Nivea, Topical Cream CI watch — JSON
- Nivea, Topical Cream alone — RSS
Cite this brief
Drug Landscape (2026). Nivea, Topical Cream — Competitive Intelligence Brief. https://druglandscape.com/ci/nivea-topical-cream. Accessed 2026-05-16.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab